Sustaining Innovation Analyst Day

Investor presentations



2018

media/Project/One-Sanofi-Web/sanofi-com/common/img/investors/bloc_2018_investor_presentations_Ircall_March2018.jpg
2018-03-10MMMM D, YYYY

IR conference call on Odyssey Outcomes

Sanofi and Regeneron conference call for the financial community on the results of the ODYSSEY OUTCOMES study.

IR call on the acquisition of Ablynx
2018-01-29MMMM D, YYYY

IR call on the acquisition of Ablynx

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Ablynx.

IR call on the acquisition of Bioverativ Inc
2018-01-22MMMM D, YYYY

IR call on the acquisition of Bioverativ Inc.

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Bioverativ Inc.

2017

Sustaining Innovation Analyst Day
2017-12-13MMMM D, YYYY

Sustaining Innovation Analyst Day

Sanofi organized an analyst meeting to discuss Sanofi’s R&D strategy and development pipeline.

Dupixent® FDA approval call
2017-03-28MMMM D, YYYY

Dupixent® FDA approval call

Sanofi and Regeneron hosted a conference call following the approval of Dupixent® in the U.S.

2016

IR thematic call on dupilumab
2016-10-01MMMM D, YYYY

IR thematic call on dupilumab

Sanofi and Regeneron hosted a conference call focusing on dupilumab.

IR thematic call – Building global leadership in Consumer Healthcare
2016-06-27MMMM D, YYYY

IR thematic call – Building global leadership in Consumer Healthcare

Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim.

2015

IR thematic call on sarilumab
2015-11-09MMMM D, YYYY

IR thematic call on sarilumab

Sanofi and Regeneron hosted a conference call on sarilumab.

Meet Sanofi Management
2015-11-06MMMM D, YYYY

Meet Sanofi Management

Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020.

IR thematic call on Praluent® FDA approval
2015-07-24MMMM D, YYYY

IR thematic call on Praluent® FDA approval

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

IR thematic call on Diabetes
2015-06-09MMMM D, YYYY

IR thematic call on Diabetes

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

2014

IR thematic seminar on New Medicines
2014-11-20MMMM D, YYYY

IR thematic seminar on New Medicines

Sanofi hosted an IR Thematic Seminar on New Medicines.

IR thematic call with Serge Weinberg
2014-10-29MMMM D, YYYY

IR thematic call with Serge Weinberg

Sanofi held a conference call with Serge Weinberg for the financial community.

IR thematic call on alirocumab
2014-09-02MMMM D, YYYY

IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.

TIR thematic call on Diabetes
2014-06-16MMMM D, YYYY

IR thematic call on Diabetes

Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions.

IR thematic call on alirocumab
2014-03-31MMMM D, YYYY

IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting.